Respiratory | GSKpro IE
Ellipta inhaler|Respiratory Overview
Incruse ▼ Ellipta (umeclidinium bromide)
Avamys (fluticasone furoate)
Home | GSKpro IE 1
Head-to-head data | Anoro Ellipta (umeclidinium/vilanterol inhalation powder)
Head-to-head data | Anoro Ellipta (umeclidinium/vilanterol inhalation powder)
Head-to-head data | Anoro Ellipta (umeclidinium/vilanterol inhalation powder)
Guidelines| Avamys (fluticasone furoate)
Efficacy & Safety | Incruse ▼ Ellipta (umeclidinium bromide)
Nucala (mepolizumab)
Environmental Impact | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Adherence | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Monitoring SABA dependence | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Quality of Life | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Exacerbations | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Proactive-asthma-control | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Trelegy(fluticasone furoate/umeclidinium/vilanterol)
Educational Materials | Volibris (ambrisentan)
Knowledge Base | Respiratory | GSKpro IE
Dovato(dolutegravir and lamivudine) | HIV
Challenges of achieving good asthma control| GSKpro IE
Anoro▼ Ellipta (umeclidinium/vilanterol inhalation powder) H2H Vs IMT Options | | Respiratory | GSKpro IE
Molecules | Anoro Ellipta (umeclidinium/vilanterol inhalation powder)
Efficacy | Avamys (fluticasone furoate)
Anoro Ellipta (umeclidinium/vilanterol inhalation powder)
Mode of Actions| Nucala (mepolizumab)
Safety| Nucala (mepolizumab)
Achieving Asthma Control | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Relvar Defining asthma control | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Device | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Cortisol and HPA Effects | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Particle Size | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Therapeutic Index | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Relvar Molecule properties | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Safety | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Shingrix ▼ (herpes zoster vaccine recombinant, adjuvanted)
Therapy Areas | GSKpro IE
Update Password | GSKpro IE
Device | Avamys (fluticasone furoate)
Rotarix (rotavirus vaccine) | GSKpro IE
Indications | Incruse ▼ Ellipta (umeclidinium bromide)
Administration | Incruse ▼ Ellipta (umeclidinium bromide)
Safety | Anoro Ellipta (umeclidinium/vilanterol inhalation powder)
Dosing & Ellipta Device | Anoro Ellipta (umeclidinium/vilanterol inhalation powder)
Shingrix ▼(herpes zoster vaccine recombinant, adjuvanted) | Vacinate | Vaccines | GSKpro IE
Zyban (bupropion hydrochloride)
Unsubscribe | GSKpro IE
Unsubscribe-lite | GSKpro IE
Efficacy| Shingrix ▼ (herpes zoster vaccine recombinant, adjuvanted)
Video Series | Vaccines | GSKpro IE
Vaccines Stock Information | Vaccines | GSKpro IE
Biologic treatment in severe eosinophilic asthma | Respiratory | Events | GSKpro IE
The Challenges of managing Severe Asthma and OCS | Events | GSKpro IE
Volibris (ambrisentan)
Coming soon | Zejula (Niraparib)
Solving the Asthma Paradox Webinar on demand | Respiratory | GSKpro IE
Translating clinical evidence to real world patients| GSKpro IE
Overview | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Report an Adverse Event | GSKpro IE
Switching to Relvar | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
The Salford Lung Study | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Patient Perception vs Reality | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Long Lasting Control | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Ellipta Device | Relvar Ellipta (fluticasone furoate/vilanterol pre-dispensed inhalation powder)
Registration | GSKpro IE
Log In | GSKpro IE
The 2DR Era | HIV | GSKpro IE
Anoro Ellipta (umeclidinium/vilanterol inhalation powder)
Ive Seen Meningitis Ep.2 | Vaccines | GSKpro IE
Ive Seen Meningitis Ep.3 | Vaccines | GSKpro IE
Ive Seen Meningitis Ep.1 | Vaccines | GSKpro IE
COPD Overview | Respiratory | GSKpro IE
HIV Therapy Area| HIV | GSKpro IE
Our Medicines | HIV | GSKpro IE
Imigran (sumatriptan)
Contact Us | GSKpro IE
Consider Mepolizumab for overlapping severe allergic and eosinophilic phenotypes | Events | GSKpro IE
Products | GSKpro IE
Shingrix (herpes zoster vaccine recombinant, adjuvanted)
Real World Experience Positive Perspectives | Dovato (dolutegravir/lamivudine)
GSKpro IRE | Recommendations
Request a Contact | GSKpro IE
Vocabria▼ Suspension for Injection
Vocabria▼ Film-Coated Tablets
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Ellipta Inhaler
Molecules & Device | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Home| Nucala (mepolizumab)
Vaccines | GSKpro IE
Safety| Shingrix ▼ (herpes zoster vaccine recombinant, adjuvanted)
Shingrix ▼(herpes zoster vaccine recombinant, adjuvanted) | Patient Profiles | Vaccines | GSKpro IE
Shingrix ▼(herpes zoster vaccine recombinant, adjuvanted) | Scientific Rationale | Vaccines | GSKpro IE
PHN-Efficacy | Shingrix ▼ (herpes zoster vaccine recombinant, adjuvanted)
Dovato (dolutegravir and lamivudine)
Resistance | Dovato (dolutegravir and lamivudine)
Tolerability | Dovato (dolutegravir/lamivudine)
Efficacy GEMIN 1&2 Dovato |(dolutegravir/lamivudine)
Efficacy STAT | Dovato(dolutegravir/lamivudine)
Efficacy TANGO| Dovato (dolutegravir/lamivudine)
Efficacy | Dovato (dolutegravir and lamivudine)
Metabolic Outcomes| Dovato (dolutegravir/lamivudine)
Real-WorldExperience | Dovato (dolutegravir/lamivudine)
Real World Experience Homepage | Dovato (dolutegravir/lamivudine)
Dovato (dolutegravir/lamivudine)
Vocabria ▼(cabotegravir)+ Rekambys ▼(rilpivirine) | GSKpro IE
Efficacy| Nucala (mepolizumab)
Identifying patients | Nucala (mepolizumab)
Safety Information| Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Health Related Quality of Life | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Lung Function | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Exacerbation Reduction | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Dosing and administration| Nucala (mepolizumab)
Resources | GSKpro IE
Network Meta Analysis
Site Map | GSKpro IE
Events | GSKpro IE
Vaccines Portfolio | Vaccines | GSKpro IE
Identifying patients | Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Coming soon | GSKpro
Home | GSKpro IE 2
Anoro Patients | Anoro Ellipta (umeclidinium/vilanterol inhalation powder)
Products | Respiratory
Show more
No results. Why not try:
- Checking the spelling of the search term
- Trying a different search term
- Resetting or revising the filter settings (if you used filters to do this search)
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie . Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
▼ These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.